Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

NCT01752894 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01752894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2013
Completion date
April 11, 2017
Enrollment
776 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease